Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 97


Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial.

Levitsky A, Brismar K, Hafström I, Hambardzumyan K, Lourdudoss C, van Vollenhoven RF, Saevarsdottir S.

RMD Open. 2017 Aug 9;3(2):e000458. doi: 10.1136/rmdopen-2017-000458. eCollection 2017.


Patients with Early Rheumatoid Arthritis in the 2000s Have Equal Disability and Pain Despite Less Disease Activity Compared with the 1990s: Data from the BARFOT Study over 8 Years.

Andersson MLE, Forslind K, Hafström I; BARFOT Study Group.

J Rheumatol. 2017 Jun;44(6):723-731. doi: 10.3899/jrheum.161235. Epub 2017 Apr 1.


Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present.

Derksen VF, Ajeganova S, Trouw LA, van der Helm-van Mil AH, Hafström I, Huizinga TW, Toes RE, Svensson B, van der Woude D.

Ann Rheum Dis. 2017 Apr;76(4):716-720. doi: 10.1136/annrheumdis-2016-209794. Epub 2016 Nov 9.


Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.

van Wesemael TJ, Ajeganova S, Humphreys J, Terao C, Muhammad A, Symmons DP, MacGregor AJ, Hafström I, Trouw LA, van der Helm-van Mil AH, Huizinga TW, Mimori T, Toes RE, Matsuda F, Svensson B, Verstappen SM, van der Woude D.

Arthritis Res Ther. 2016 Dec 1;18(1):285.


Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus.

Lourdudoss C, Elkan AC, Hafström I, Jogestrand T, Gustafsson T, van Vollenhoven R, Frostegård J.

Lupus. 2016 Dec;25(14):1602-1609. Epub 2016 Jun 22.


Persistently active disease is common in patients with rheumatoid arthritis, particularly in women: a long-term inception cohort study.

Svensson B, Andersson M, Forslind K, Ajeganova S, Hafström I; BARFOT study group.

Scand J Rheumatol. 2016 Nov;45(6):448-455. Epub 2016 Apr 20.


The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.

Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafström I, Toes RE, Huizinga TW, Svensson B, Trouw LA, van der Helm-van Mil AH.

Ann Rheum Dis. 2017 Jan;76(1):112-118. doi: 10.1136/annrheumdis-2015-208870. Epub 2016 Apr 26.


IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.

Rahman M, Sing S, Golabkesh Z, Fiskesund R, Gustafsson T, Jogestrand T, Frostegård AG, Hafström I, Liu A, Frostegård J.

Clin Immunol. 2016 May;166-167:27-37. doi: 10.1016/j.clim.2016.04.007. Epub 2016 Apr 19.


The association between diet and glucocorticoid treatment in patients with SLE.

Lourdudoss C, Hafström I, Frostegård J, van Vollenhoven R.

Lupus Sci Med. 2016 Jan 27;3(1):e000135. doi: 10.1136/lupus-2015-000135. eCollection 2016.


Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.

Ajeganova S, Humphreys JH, Verheul MK, van Steenbergen HW, van Nies JA, Hafström I, Svensson B, Huizinga TW, Trouw LA, Verstappen SM, van der Helm-van Mil AH.

Ann Rheum Dis. 2016 Nov;75(11):1924-1932. doi: 10.1136/annrheumdis-2015-208579. Epub 2016 Jan 12.


Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study.

Ajeganova S, Gustafsson T, Jogestrand T, Frostegård J, Hafström I.

Arthritis Res Ther. 2015 Mar 25;17:84. doi: 10.1186/s13075-015-0595-4.


Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis - A BARFOT Study.

Andersson ML, Forslind K, Hafström I.

Open Rheumatol J. 2015 Feb 3;9:8-15. doi: 10.2174/1874312901409010008. eCollection 2015.


Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study.

Hafström I, Engvall IL, Rönnelid J, Boonen A, van der Heijde D, Svensson B; BARFOT study group.

BMJ Open. 2014 Jul 30;4(7):e005246. doi: 10.1136/bmjopen-2014-005246.


Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial.

Ajeganova S, Svensson B, Hafström I; BARFOT Study Group.

BMJ Open. 2014 Apr 7;4(4):e004259. doi: 10.1136/bmjopen-2013-004259.


Low levels of antibodies against oxidized but not nonoxidized cardiolipin and phosphatidylserine are associated with atherosclerotic plaques in systemic lupus erythematosus.

Su J, Frostegård AG, Hua X, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.

J Rheumatol. 2013 Nov;40(11):1856-64. doi: 10.3899/jrheum.121173. Epub 2013 Sep 15.


Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria.

Svensson B, Andersson ML, Bala SV, Forslind K, Hafström I; BARFOT study group.

BMJ Open. 2013 Sep 10;3(9):e003554. doi: 10.1136/bmjopen-2013-003554.


Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.

Ajeganova S, Andersson ML, Frostegård J, Hafström I.

J Rheumatol. 2013 Dec;40(12):1958-66. doi: 10.3899/jrheum.130365. Epub 2013 Aug 15.


Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.

Andersson ML, Svensson B, Petersson IF, Hafström I, Albertsson K, Forslind K, Heinegård D, Saxne T.

BMC Musculoskelet Disord. 2013 Aug 2;14:229. doi: 10.1186/1471-2474-14-229.

Supplemental Content

Loading ...
Support Center